SNT 12.5% 4.5¢ syntara limited

My mistake.U.S. FDA ACCEPTS ARIDOLTM NEW DRUG APPLICATION FOR...

  1. 509 Posts.
    My mistake.
    U.S. FDA ACCEPTS ARIDOLTM NEW DRUG APPLICATION FOR REVIEW
    Pharmaxis (ASX:PXS, NASDAQ:PXSL) today announced it had received notification from the United
    States Food and Drug Administration (FDA) that the New Drug Application (NDA) for its mannitol
    bronchial challenge test Aridol™ has been accepted for standard review. The FDA will advise the
    result of the review on 27 December 2009.

 
watchlist Created with Sketch. Add SNT (ASX) to my watchlist
(20min delay)
Last
4.5¢
Change
0.005(12.5%)
Mkt cap ! $61.79M
Open High Low Value Volume
4.1¢ 4.5¢ 4.1¢ $64.59K 1.523M

Buyers (Bids)

No. Vol. Price($)
1 58240 4.3¢
 

Sellers (Offers)

Price($) Vol. No.
4.5¢ 208212 2
View Market Depth
Last trade - 16.10pm 19/11/2024 (20 minute delay) ?
SNT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.